Volume 25 Number 5 - Australian Prescriber

Australian Prescriber

Volume 25 Number 5 - October 2002

Editorial

Can we afford intensive management of diabetes?
(Editorial) B. Pekarsky & B. Ewald

Transparency and the Pharmaceutical Benefits Advisory Committee
L. Sansom

Sensitivity and specificity - is your test reliable?

Experimental and clinical pharmacology

Experimental and clinical pharmacology
New drugs for colorectal cancer - mechanisms of action
L.P. Rivory

Experimental and clinical pharmacology

Experimental and clinical pharmacology
New treatments for advanced and metastatic colorectal cancer - clinical applications
S. Clarke

Perceptions of risk - a legal perspective
J. McPhee

Drug treatment of macular degeneration
R. Guymer

Patient support organisation

Retina Australia

How we write about new drugs
J.S. Dowden

New drugs
amisulpride
modafinil
peginterferon alfa-2b
reboxetine mesylate

National Prescribing Service
Medicines Line

Australian Prescriber Cover

click to download
the full PDF issue

To view and print the PDF print versions you may need to download and install Acrobat Reader by clicking on the button below

Free subscription